BP Growth Partners

BP Growth Partners is a private equity fund manager based in the Midwest, specializing in investments alongside management teams of private, middle-market companies. The firm focuses on providing capital for growth, liquidity, ownership transitions, and acquisitions. Currently managing two funds, BP Growth Partners has plans to launch a third fund. The principals of the firm possess extensive experience in advising and investing in private companies throughout various stages of their corporate lifecycles. BP Growth Partners differentiates itself through its tailored approach, aligning interests with the companies it partners with and concentrating on select sectors. Their commitment extends beyond mere investment; they aim to create meaningful impacts through innovative ideas, technology, and strategies.

Adam Claypool

Managing Principal

10 past transactions

BettrLife

Seed Round in 2012
BettrLife is a nutrition-focused technology platform designed to help individuals manage their long-term health and wellness. The platform offers advanced tools for planning and logging food and activity, accessible via mobile devices and the web. It features a two-way health coaching system that facilitates direct engagement between users and health coaches, promoting healthier lifestyle choices and improving compliance. By utilizing real-time cloud synchronization, BettrLife enables fitness clubs and dietitians to efficiently oversee and enhance the health outcomes of their clients and patients. The platform aims to empower users in achieving their wellness goals while potentially reducing healthcare costs.

Cyber-Rain

Series B in 2010
Cyber-Rain specializes in innovative wireless sprinkler control systems designed for homeowners, property managers, building owners, and landscape contractors. The company's smart sprinkler technology enables users to significantly reduce landscape watering costs, achieving savings of 30 to 70 percent. By leveraging automatic weather updates from the internet and user-friendly computer interfaces, Cyber-Rain provides an efficient and convenient solution for managing irrigation needs.

BirdDog Technology

Venture Round in 2010
BirdDog specializes in developing and manufacturing audio-visual technology, including 4K broadcast video converters and robotic pan-tilt-zoom cameras. The company also offers software solutions that enhance video quality, speed, and flexibility. In addition to its hardware offerings, BirdDog provides recruitment and applicant tracking solutions that facilitate candidate sourcing, screening, and management. Its cloud-based platform helps organizations streamline communication, improve candidate flow, shorten hiring times, and reduce recruitment costs. The company's diverse client base spans various industries, with a notable focus on construction, engineering, and supply. Most of BirdDog's product sales are concentrated in the North American market.

Consumer Health Advisers

Series B in 2010
Consumer Health Advisers specializes in providing on-demand consumer health information tailored for employees and dependents of self-insured employers. The company operates a web-based platform known as the Consumer Health Management Center (CHMC), which integrates health history, claims, and financial data into a single accessible portal. Key offerings include Health Record Plus, which transforms personalized claims information into actionable insights, and Health Record, a module that creates pre-populated personal health records. Additionally, Consumer Health Advisers delivers public sector solutions aimed at Medicare and Medicaid populations, equipping clients with automated health guidance, financial decision support tools, and on-demand coaching. This comprehensive approach empowers employees to make informed healthcare decisions and manage their health proactively.

Palisade Systems

Venture Round in 2009
Palisade Systems, Inc. specializes in enterprise content security and data protection solutions, offering a range of products designed to safeguard sensitive information and manage network traffic. Its key offerings include PacketSure, which protects private data; PacketGuard, which secures devices from unauthorized access; PacketDecoy, which intercepts and gathers intelligence on potential intruders; and ScreenDoor, which manages and restricts internet access. These solutions help protect intellectual property and client information, enforce access controls, and ensure compliance with privacy regulations. Palisade serves a diverse clientele, including healthcare, financial services, insurance sectors, and educational institutions across North America and Europe. Founded in 1996 in Ames, Iowa, the company is now headquartered in Des Moines, Iowa.

Consumer Health Advisers

Series A in 2009
Consumer Health Advisers specializes in providing on-demand consumer health information tailored for employees and dependents of self-insured employers. The company operates a web-based platform known as the Consumer Health Management Center (CHMC), which integrates health history, claims, and financial data into a single accessible portal. Key offerings include Health Record Plus, which transforms personalized claims information into actionable insights, and Health Record, a module that creates pre-populated personal health records. Additionally, Consumer Health Advisers delivers public sector solutions aimed at Medicare and Medicaid populations, equipping clients with automated health guidance, financial decision support tools, and on-demand coaching. This comprehensive approach empowers employees to make informed healthcare decisions and manage their health proactively.

Zevra Therapeutics

Series B in 2009
Zevra Therapeutics is a development-stage biopharmaceutical company focused on creating new therapies for pain, ADHD, and other central nervous system (CNS) diseases, particularly in the realm of rare diseases. The company is dedicated to developing safer, abuse-resistant opioid pain relievers and employs a proprietary Ligand Activated Therapy (LAT) approach to drug discovery and development. This innovative platform allows Zevra to enhance existing medications and streamline the development process while preserving strong intellectual property rights. By integrating scientific research with patient needs and data-driven strategies, Zevra Therapeutics aims to address the challenges of drug development, delivering transformational therapies for conditions with limited or no treatment options.

GCommerce

Series E in 2008
GCommerce, Inc. is a company that specializes in providing cloud-based automation solutions specifically tailored for the durable goods distribution industry. Founded in 2000 and based in Des Moines, Iowa, GCommerce offers a range of software-as-a-service products designed to streamline supply chain operations. Its offerings include AutoSoEZ, an e-commerce platform, and PBEPRO, which connects manufacturers with a targeted audience of jobbers and warehouse distributors in the United States and Canada. The company also provides the Internet Data Exchange for real-time electronic data interchange, Virtual Inventory Cloud for supply chain issues, Match3 for automating purchase order reconciliations, Web Gateway for electronic document exchange, and Super Spec for standardizing data definitions among trading partners. Through these solutions, GCommerce aims to enhance communication and efficiency within the distribution supply chain, ultimately reducing costs and improving sales outcomes for its clients.

TrueChoice

Venture Round in 2008
TrueChoice Solutions Inc., established in 2006, specializes in on-demand preference-measurement solutions, primarily serving Fortune 1000 clients globally. The company offers Predictive Selling, Lead Generation, Customer Insight, Channel Insight, and HR Optimization software solutions. These applications, facilitated through web-enabled devices or guided by advisors, provide unique insights into customer purchase preferences, market trends, and employee benefit preferences. TrueChoice's patented econometric technologies enable real-time, quantifiable, and actionable insights, helping clients enhance customer experience, drive sales, and improve profitability. The company operates in New York, Houston, Los Angeles, Düsseldorf, and Auckland.

Zevra Therapeutics

Series A in 2008
Zevra Therapeutics is a development-stage biopharmaceutical company focused on creating new therapies for pain, ADHD, and other central nervous system (CNS) diseases, particularly in the realm of rare diseases. The company is dedicated to developing safer, abuse-resistant opioid pain relievers and employs a proprietary Ligand Activated Therapy (LAT) approach to drug discovery and development. This innovative platform allows Zevra to enhance existing medications and streamline the development process while preserving strong intellectual property rights. By integrating scientific research with patient needs and data-driven strategies, Zevra Therapeutics aims to address the challenges of drug development, delivering transformational therapies for conditions with limited or no treatment options.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.